INCLIVA
Contact information
- Biodrugs
- Biomarkers
- Stem cells
- Cell cultures
- Biological defense
- In vitro diagnostics
- Diagnostic imaging
- Medical devices
- Drug delivery
- Drug development
- Drug discovery
- Blood products
- Screening
- Cellular Therapy
- Gene Therapy
- Biomaterials and tissue therapy
- Transplant
- Vaccines
- Substance abuse
- Analgesia & Pain
- Dermatology
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Inflammatory diseases
- Gynaecology and obstetrics
- Immunology
- Odontology
- Ophtalmology and optometry
- Oncology
- Blood and lymphatic system
- Digestive system and hepatology
- Kidney and genitourinary system
- Central nervous system
- Respiratory and pulmonary system
- Metabolic disorders / Endocrinology
- Vitamins and nutrition products
- Bioinformatics
- Pharmacogenomics
- Genomics
- Metabolomics
- Proteomics
Its mission is to generate cutting-edge biomedical knowledge, promote innovation and the transfer of research findings to clinical practice, and improve people’s health and quality of life through research, training, and collaboration with the healthcare system, universities, and the business community.
- Participation in national and international collaborative R&D&I projects.
- Clinical validation of health technologies.
- Clinical trials.
- Pilot studies and validation in real-world healthcare settings.
- Usability testing and co-creation with users within the Living Lab framework.
- Technology transfer.
- Protection and commercialization of research results.
- Identification of collaboration opportunities between companies and research groups.
- Access to specialized scientific and technical services such as the Biobank, Precision Medicine Unit, Bioinformatics Unit, Biostatistics Unit, Body Composition Unit, Biomarker Analysis Unit, Molecular, Cellular, and In Vivo Analysis Unit, Analytical Liquid Chromatography Unit, and Mass Spectrometry Unit
INCLIVA is interested in establishing partnerships with public and private entities for the development, validation, and transfer of innovative health technologies. Areas of interest include collaborative R&D&I projects, personalized medicine, digital health and artificial intelligence, medical devices, in vitro diagnostics, biomarkers, advanced therapies, clinical trials, clinical and regulatory validation, usability testing and co-creation through the Living Lab, data science and bioinformatics, as well as initiatives for the commercialization and transfer of research results.